Groupama Asset Management Invests $873,000 in IDEXX Laboratories

The investment firm bought a new stake in the veterinary diagnostics company during the third quarter.

Mar. 21, 2026 at 9:20am

Groupama Asset Management, a French investment firm, bought a new stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) during the third quarter of 2026. The firm purchased 1,367 shares of the company's stock, valued at approximately $873,000.

Why it matters

IDEXX Laboratories is a leading global provider of diagnostic products and services for the animal health, water testing, and food safety markets. The investment by Groupama Asset Management suggests the firm sees growth potential in IDEXX's business and the broader veterinary diagnostics industry.

The details

According to a filing with the U.S. Securities and Exchange Commission, Groupama Asset Management acquired the new stake in IDEXX Laboratories during the third quarter. IDEXX is a major supplier of in-clinic diagnostic instruments, consumables, reference laboratory testing, and practice-management tools for veterinarians, livestock and dairy producers, and food producers worldwide.

  • Groupama Asset Management bought the new stake in IDEXX Laboratories during the third quarter of 2026.

The players

Groupama Asset Management

A French investment firm that bought a new stake in IDEXX Laboratories.

IDEXX Laboratories, Inc.

A global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

Groupama Asset Management's investment in IDEXX Laboratories suggests the firm sees strong growth potential in the veterinary diagnostics industry, which is a key focus area for IDEXX. This highlights the continued investor interest in companies providing innovative solutions to support animal health and food safety.